Skip to content

Effectiveness of Computerized Device New of Visual Motor Simulation Versus Mirror Therapy in Hemiplegic Patients.

Effectiveness of Computerized Device New of Visual Motor Simulation Versus Mirror Therapy in Hemiplegic Patients. SI-VIM Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04025411
Acronym
SI-VIM
Enrollment
37
Registered
2019-07-18
Start date
2019-10-28
Completion date
2023-07-06
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Upper limb rehabilitation, Computerized mirror therapy, Hemiparetic, Mirror therapy

Brief summary

Mirror Therapy (TM) has been shown to be effective in motor rehabilitation of the hemiplegic upper limb, but its implementation in current clinical practice has several difficulties, both from the patient and physiotherapist point of view. A new computerized Mirror Therapy (TM) device (Intensive Visual Simulation 3 (IVS3), Dessintey) which aims to solve the TM compliance problems and make it more efficient have been developed.

Detailed description

The aim of this study is to compare the observance and efficiency of the Intensive Visual Simulation 3 (IVS3) therapy as compared to traditional Mirror Therapy (TM) in a population of hemiplegic stroke patients.

Interventions

DEVICEIntensive Visual Simulation 3 (IVS3) device

Visual motor simulation with the Intensive Visual Simulation 3 (IVS3) device will be realized and consist of 5 sessions per week for 4 weeks (20 minutes). The patient looks on a screen in front of him, mirroring the movements made by his healthy hand, while attempting to perform the same movement with his paretic hand.

DEVICEtraditional Mirror Therapy (TM)

Simulation with the traditional Mirror Therapy (TM) will be realized and consist of 5 sessions per week for 4 weeks (20 minutes).

DEVICEElectroencephalography (EEG)

Electroencephalography (EEG) will be performed during the 1st, 6th, 11th, 16th and 20th session of their programme will be made in order to evaluate brain activity.

Sponsors

Saint-Etienne Métropole
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* First ischemic or hemorrhagic stroke for less than one year * Not having reoffend * Responsible for an initially complete hemiplegia, * Upper-limb deficiency with the modified Frenchay Score below 70, * Not neurological history other than stroke, * Having signed the written consent * Affiliated or entitled to a social security scheme

Exclusion criteria

* Patient who have not Magnetic Resonance Images (MRI) of the brain during stroke * Having complete lesion of the primary motor cortex * With an addiction to alcohol or drugs * With psychiatric illness, cognitive impairment, uncontrolled disease / epilepsy, malignancy, severe renal or pulmonary impairment * History of associated disabling general disease * With associated cerebellar syndrome * With clinical involvement of the brainstem * Pregnancy in progress * Patients under the protection of justice.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Fugl-Meyer motor assessment score at 18 days, at 32 days, and at 60 daysDay: 0, 18, 32, 60Measured by Fugl-Meyer motor assessment score at baseline, at 18 days, at 32 days, and at 60 days. Fugl-Meyer score assesses the analytical motor skills of the upper limb with minimum score at 0 (hemiplegia) and maximum score at 66 (normal motor performance).

Secondary

MeasureTime frameDescription
Change from baseline modified Frenchay Arm Test score at 18 days, at 32 days, and at 60 days.Day: 0, 18, 32, 60Measured by Frenchay Arm Test score at baseline, at 18 days, at 32 days, and at 60 days. Frenchay Arm Test score assesses functional improvement of the activities of the upper limb paretics with minimum score at 0 (total dependence) and maximum score at 100 (complete autonomy).
Change from baseline Barthel index at 18 days, at 32 days, and at 60 days.Day: 0, 18, 32, 60Measured by Barthel index at baseline, at 18 days, at 32 days, and at 60 days. Barthel index assesses autonomy with minimum score at 0 (total dependence) and maximum score at 100 (complete autonomy).
Change from baseline Abilhand questionnaire at 18 days, at 32 days, and at 60 days.Day: 0, 18, 32, 60Measured by Abilhand questionnaire at baseline, at 18 days, at 32 days, and at 60 days. Abilhand questionnaire will allow self-evaluation of the function of the upper limb in daily life with minimum score at 0 (difficulties in daily life) and maximum score at 46 (no difficulties in daily life).
Analysis of brain activityMonth: 2Measured by Electroencephalography (EEG) results.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026